For anyone working in the health and life sciences industries and looking to complete a few final CLE hours before the end of 2025, Reed...
Reed Smith LLP
This is the second in a series of blog posts designed to provide a deeper dive into the provisions of the 2025 Reconciliation Law...
The California Senate has approved SB 41, a bill now under consideration in the Assembly, that would impose new licensing, transparency,...
On May 12, 2025, the Trump Administration released Executive Order 14297, entitled “Delivering Most-Favored-Nation Drug Pricing to...
The Department of Health and Human Services Office of Inspector General (“OIG”) recently issued a favorable advisory opinion that relates...
On Nov. 8, 2023, the Senate Finance Committee voted 26-0 to approve the Better Mental Health, Lower Cost Drugs, and Extenders Act. Among...
The Centers for Medicare and Medicaid Services (CMS) released the names of the top 10 drugs by Medicare spend on Aug. 29. The list is the...
The Inflation Reduction Act included some very significant changes to the ways in which the Medicare program handles drug pricing. Among...
On August 12, 2021, the Seventh Circuit joined the Third, Eighth, Ninth, and D.C. Circuits in holding that the “objective reasonableness”...